RecruitingPhase 1 / Phase 2NCT04977453
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Sponsor: GI Innovation, Inc.
Huntersville, NC · +2 more sites
Clinical trials in Huntersville, NC
17 recruiting studies have a site in or near Huntersville, NC, North Carolina.
Top conditions here
- Breast Cancer (6)
- Lung Cancer (5)
- Colorectal Cancer (3)
- Prostate Cancer (2)
- Asthma (2)
- Psoriasis (1)
- Type 1 Diabetes (1)
- Type 2 Diabetes (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 17 of 17 studies
RecruitingPhase 1NCT06545331
Study of XB010 in Subjects With Solid Tumors
Sponsor: Exelixis
Huntersville, NC · +15 more sites
RecruitingPhase 2NCT06977581
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Sponsor: Pfizer
Charlotte, NC · Gastonia, NC · Huntersville, NC · +33 more sites
RecruitingPhase 1NCT07161414
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
Sponsor: AstraZeneca
Huntersville, NC · +2 more sites
RecruitingPhase 3NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Fayetteville, NC · Greensboro, NC · Greenville, NC · +232 more sites
RecruitingPhase 2NCT06932263
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Sponsor: AstraZeneca
Asheville, NC · Huntersville, NC · Kings Mountain, NC · +61 more sites
RecruitingPhase 1 / Phase 2NCT05267626
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Sponsor: Aulos Bioscience, Inc.
Huntersville, NC · +9 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Cary, NC · Huntersville, NC · +37 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Albemarle, NC · Asheboro, NC · +1223 more sites
RecruitingPhase 1NCT07241039
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
Sponsor: AbbVie
Huntersville, NC · +5 more sites
RecruitingPhase 1 / Phase 2NCT06751329
A Study of DM002 in Patients With Advanced Solid Tumors
Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Huntersville, NC · +3 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Albemarle, NC · Asheboro, NC · +825 more sites
RecruitingPhase 3NCT06748222
E-Mindfulness Approaches for Living After Breast Cancer
Sponsor: NRG Oncology
Albemarle, NC · Asheboro, NC · Burlington, NC · +378 more sites
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Albemarle, NC · Asheville, NC · +809 more sites
RecruitingPhase 1 / Phase 2NCT07030257
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Sponsor: Tasca Therapeutics
Huntersville, NC · +12 more sites
RecruitingPhase 1NCT07317505
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Sponsor: Conjupro Biotherapeutics, Inc.
Huntersville, NC · +2 more sites
RecruitingPhase 1NCT06999187
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Sponsor: Dren Bio
Huntersville, NC · +9 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.